The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
Open accessAbstract
Switching to a glycolytic metabolism is a rapid adaptation of tumor cells to hypoxia. Although this metabolic conversion may primarily represent a rescue pathway to meet the bioenergetic and biosynthetic demands of proliferating tumor cells, it also creates a gradient of lactate that mirrors the gradient of oxygen in tumors. More than a metabolic waste, the lactate anion is known to participate to cancer aggressiveness, in part through activation of the hypoxia-inducible factor-1 (HIF-1) pathway in tumor cells. Whether lactate may also directly favor HIF-1 activation in endothelial cells (ECs) thereby offering a new druggable option to block angiogenesis is however an unanswered question. In this study, we therefore focused on the role in ECs of monocarboxylate transporter 1 (MCT1) that we previously identified to be the main facilitator of lactate uptake in cancer cells. We found that blockade of lactate influx into ECs led to inhibition of HIF-1-dependent angiogenesis. Our demonstration is based on the unprecedented characterization of lactate-induced HIF-1 activation in normoxic ECs and the consecutive increase in vascular endothelial growth factor receptor 2 (VEGFR2) and basic fibroblast growth factor (bFGF) expression. Furthermore, using a variety of functional assays including endothelial cell migration and tubulogenesis together with in vivo imaging of tumor angiogenesis through intravital microscopy and immunohistochemistry, we documented that MCT1 blockers could act as bona fide HIF-1 inhibitors leading to anti-angiogenic effects. Together with the previous demonstration of MCT1 being a key regulator of lactate exchange between tumor cells, the current study identifies MCT1 inhibition as a therapeutic modality combining antimetabolic and anti-angiogenic activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, lactate accumulation is instrumental for the promotion of angiogenesis.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Sonveaux et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“transporter 4 (MCT4) and key pro-angiogenic effectors such as vascular endothelial growth factor (VEGF) [11,12].”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 2,011
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–541 of 541
Philips, T., Thompson, E. G., Spead, O., Vijayakumar, B. G., Kent, E. R., Miller, S., Nwokeleme, T., Vidensky, S., Farah, M. H., & Rothstein, J. D. (2025) · Glia · doi:10.1002/glia.70113
Huang, A., Sun, Z., Hong, H., Yang, Y., Chen, J., Gao, Z., & Gu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26737023
Collin, L. J., Maliniak, M. L., Cronin-Fenton, D. P., Ahern, T. P., Christensen, K. B., Ulrichsen, S. P., Damkier, P., Hamilton-Dutoit, S. J., Yacoub, R., Christiansen, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16935503
Huang, A., Sun, Z., Hong, H., Yang, Y., Chen, J., Gao, Z., & Gu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26737026
Yang, Y., Dai, D., Jin, W., Huang, Y., Zhang, Y., Chen, Y., Wang, W., Lin, W., Chen, X., Zhang, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256665
Yang, Y., Dai, D., Jin, W., Huang, Y., Zhang, Y., Chen, Y., Wang, W., Lin, W., Chen, X., Zhang, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256668
Yang, Y., Dai, D., Jin, W., Huang, Y., Zhang, Y., Chen, Y., Wang, W., Lin, W., Chen, X., Zhang, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256656
Yang, Y., Dai, D., Jin, W., Huang, Y., Zhang, Y., Chen, Y., Wang, W., Lin, W., Chen, X., Zhang, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256659
Yang, Y., Dai, D., Jin, W., Huang, Y., Zhang, Y., Chen, Y., Wang, W., Lin, W., Chen, X., Zhang, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256662
Macrophage Glucose Metabolism Reprogramming in Inflammatory Bowel Disease
姬, 艳. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.163807
The role of gut microbiota in the development, diagnosis, and treatment of gastric cancer
Hu, M., Xiao, Y., Zhang, X., Guo, J., Shen, T., Wang, Y., Deng, J., & Liu, D. Y. (2026) · Folia Microbiologica · doi:10.1007/s12223-026-01442-0
Cormerais, Y. (2016) · theses.fr (ABES) · doi:10.70675/94cc6971z3a1dz454fzb65dzf153dc0a3a05
Impact de l’acide lactique sur le phénotype et le métabolisme des macrophages humains
Paolini, L. (2018) · theses.fr (ABES) · doi:10.70675/1588aa66z8794z4b07z9a33z8b26f2ceafa4
Injarabian, L. (2020) · theses.fr (ABES) · doi:10.70675/d505f876z0405z4419zbe01z07bf7a8dc156
Biochemical characterization of mTORC1 regulation by glutamine metabolism
Bodineau, C. (2020) · theses.fr (ABES) · doi:10.70675/9d5aaabdz81bdz4118zb3edze237bdd8dee0
Rôle des flux de lactate dans le métabolisme des tissus adipeux beiges et bruns
Lagarde, D. (2020) · theses.fr (ABES) · doi:10.70675/6dfcfe91z26c5z42a8z8f53zb5a5be6082a4
Métabolisme redox et plasticité tissulaire des tissus adipeux
Jeanson, Y. (2015) · theses.fr (ABES) · doi:10.70675/0a5580f9z0185z4ab1zba28zb59c62a27680
The Role of the Microbiome in Cancer Development
Wang, Y., Shi, Y., Duan, J., Tang, H., Liu, S., & Yang, J. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i1.19
Xu, Z., Wang, X., Li, J., Zhang, X., & Wang, X. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1697031
Rouse, K. C., Törő, G., Szaniszlo, P., Govar, A. A., Servantes, B. J., Chao, C., Szabo, C., Phatak, U. R., Qiu, S., Hellmich, M. R., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.007
Metabolic Cross Talk in the Tumor Microenvironment
Das, C., Dash, S. R., Das, B., Chatterjee, S., & Parija, T. (2026) · Cancer treatment and research · doi:10.1007/978-3-032-21861-2_7
Park, J., Sharma, N., Sakhrie, A., Zhu, Y., Erel‐Akbaba, G., Bhaskar, N., Li, Z., Prasadh, S., Singh, P., Huang, F., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec8210
Glucose and Lactate, Starters or Intermediates of Cancer Metabolic Rewiring
Mendes, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_2
CircRNA circuits orchestrate lactate metabolism in gastrointestinal cancer progression
Chen, Q., Zhou, H., Shen, Z., Zhou, Y., Ding, J., 段昌虎, Cao, X., Liu, Y., Wang, L., & He, W. (2026) · Open Life Sciences · doi:10.1515/biol-2025-1351
Franczak, J., & Latif, A. (2026) · Cancers · doi:10.3390/cancers18162699
The role of lactate metabolism in uterine spiral artery remodelling
Bai, L., Fu, X., & Luo, Q. (2026) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2026.104958
Metabolism meets inflammation: lactate and lactylation in inflammatory pathogenesis
Huang, X., Zhu, Y., Guo, R., Qiu, W., & Fang, F. (2026) · Oral Science and Homeostatic Medicine · doi:10.26599/oshm.2026.9610067
Chen, J., He, A., Zhu, S., Xia, Y., & Yang, L. (2026) · The Journal of Pathology · doi:10.1002/path.70132
Monocarboxylate transporters in physiology and cancer: from fundamentals to clinical translation
Afonso, J., Pereira-Vieira, J., Miranda‐Gonçalves, V., Granja, S., Pinheiro, C. M., & Baltazar, F. (2026) · Physiological Reviews · doi:10.1152/physrev.00004.2026
Cdc42 in Tumor Hypoxia: Molecular Mechanisms of Cellular Adaptation
Askarova, S., Kadyr, S., Yermekova, A., Zhuraliyeva, A., Zhanadilova, B., Бегимбетова, Д., & Umbayev, B. A. (2026) · Oxygen · doi:10.3390/oxygen6040032
Wang, S., Gan, P., Chen, Y., Yang, B., Ding, T., & Wu, H. W. (2026) · Immunology · doi:10.1111/imm.70215
BindingDB Entry 50021148: pH regulators and their inhibitors in tumor microenvironment.
BindingDB (2025) · UC San Diego · doi:10.7270/q20g3qsk
BindingDB Entry 50046028: Monocarboxylate transporter 1 inhibitors as potential anticancer agents.
BindingDB (2016) · UC San Diego · doi:10.7270/q2zc84mv
BindingDB (2023) · UC San Diego · doi:10.7270/q2m61qbt
Kim, N., Choi, E.-Y., Chae, S., Jeong, J.-Y., Kim, H. K., & Oh, W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.26.762059
Xin, Y., Wang, X., Wu, Y., Liu, Q., Ren, Q., Wang, H., & Zhai, J. (2026) · MedComm · doi:10.1002/mco2.71100
Singh, D. D., Yadav, D. K., & Shin, D. (2026) · Antioxidants · doi:10.3390/antiox15111414
Tumor hypoxia and hypoxic markers in non-small cell lung cancer
Eilertsen, M. (2014) · NORA - Norwegian Open Research Archives
Metadata
- Authors
- Sonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., Gallez, B., Ribeiro, A., Michiels, C., Dewhirst, M. W., & Feron, O.
- Affiliations
- Duke Medical Center (US)
- UCLouvain (BE)
- Duke University (US)
- University of Namur (BE)
- Corresponding author
- Sonveaux, Pierre
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-13
- Volume
- 7
- Issue
- 3
- Pages
- e33418
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3302812
- OpenAlex
- W2003842905
- Cited by
- 536
- References
- 67
- Citations by year
- 2026: 34 · 2025: 38 · 2024: 25 · 2023: 50 · 2022: 58 · 2021: 46 · 2020: 62 · 2019: 34 · 2018: 36 · 2017: 36 · 2016: 30 · 2015: 32 · 2014: 26 · 2013: 22 · 2012: 6
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Repository of the University of Namur (submittedVersion, other-oa)
- Funders
- Belgian American Educational Foundation
- Fonds De La Recherche Scientifique - FNRS
- National Institutes of Health (FP7/2007-2013, 5p01ca042745-23)
- National Cancer Institute (CA40355, R01CA040355, CA40355-24, P01-CA042745, CA40355-25)
- FP7 Ideas: European Research Council (243188)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- MCT1, MCT1 inhibition, lactate transport, endothelial cells, tumor angiogenesis, tumor hypoxia, glycolytic metabolism, VEGFR2, basic fibroblast growth factor, anti-angiogenic therapy, tumor microenvironment
- MeSH terms
- Monocarboxylate Transport Protein 1, Analysis of Variance, Animals, Cell Movement, Enzyme-Linked Immunosorbent Assay, Fibroblast Growth Factors, Humans, Immunohistochemistry, Luciferases, Neoplasms, Neovascularization, Pathologic, Blotting, Western, Polymerase Chain Reaction, Lactic Acid, Nuclear Magnetic Resonance, Biomolecular, Monocarboxylic Acid Transporters, Symporters, RNA Interference, RNA, Small Interfering, Vascular Endothelial Growth Factor Receptor-2, Endothelial Cells, Mice, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
